#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Folic acid ( FA ) is a known water-soluble B-vitamin comprising three sub-components : A pterin ring , p-aminobenzoyl residue , and L-glutamic acid (
2-1	16-21	Folic	person|substance[3]	new|new[3]	coref	2-7[5_3]
2-2	22-26	acid	substance[3]	new[3]	_	_
2-3	27-28	(	_	_	_	_
2-4	29-31	FA	abstract	new	coref	5-8
2-5	32-33	)	_	_	_	_
2-6	34-36	is	_	_	_	_
2-7	37-38	a	substance[5]	giv[5]	appos	2-23[12_5]
2-8	39-44	known	substance[5]	giv[5]	_	_
2-9	45-58	water-soluble	substance[5]	giv[5]	_	_
2-10	59-68	B-vitamin	substance[5]	giv[5]	_	_
2-11	69-79	comprising	_	_	_	_
2-12	80-85	three	abstract[6]	new[6]	appos	2-15[9_6]
2-13	86-100	sub-components	abstract[6]	new[6]	_	_
2-14	101-102	:	_	_	_	_
2-15	103-104	A	object[8]|abstract[9]	new[8]|giv[9]	_	_
2-16	105-111	pterin	person|object[8]|abstract[9]	new|new[8]|giv[9]	_	_
2-17	112-116	ring	object[8]|abstract[9]	new[8]|giv[9]	_	_
2-18	117-118	,	abstract[9]	giv[9]	_	_
2-19	119-133	p-aminobenzoyl	abstract[9]|substance|substance[11]	giv[9]|new|new[11]	_	_
2-20	134-141	residue	abstract[9]|substance[11]	giv[9]|new[11]	_	_
2-21	142-143	,	abstract[9]	giv[9]	_	_
2-22	144-147	and	abstract[9]	giv[9]	_	_
2-23	148-158	L-glutamic	abstract[9]|substance[12]	giv[9]|giv[12]	_	_
2-24	159-163	acid	abstract[9]|substance[12]	giv[9]|giv[12]	_	_
2-25	164-165	(	_	_	_	_

#Text=Figure 1
3-1	166-172	Figure	object[13]	new[13]	ana	5-1[0_13]
3-2	173-174	1	object[13]	new[13]	_	_

#Text=) .
4-1	175-176	)	_	_	_	_
4-2	177-178	.	_	_	_	_

#Text=It is linked with different diseases ; FA prevents birth defects of the brain and spinal cord , especially spina bifida , and decreases serum homocysteine levels , reducing the risk of heart diseases .
5-1	179-181	It	object	giv	_	_
5-2	182-184	is	_	_	_	_
5-3	185-191	linked	_	_	_	_
5-4	192-196	with	_	_	_	_
5-5	197-206	different	abstract[15]	new[15]	coref	5-33[25_15]
5-6	207-215	diseases	abstract[15]	new[15]	_	_
5-7	216-217	;	_	_	_	_
5-8	218-220	FA	substance	giv	coref	6-1
5-9	221-229	prevents	_	_	_	_
5-10	230-235	birth	event|abstract[18]	new|new[18]	_	_
5-11	236-243	defects	abstract[18]	new[18]	_	_
5-12	244-246	of	abstract[18]	new[18]	_	_
5-13	247-250	the	abstract[18]|object[19]	new[18]|new[19]	_	_
5-14	251-256	brain	abstract[18]|object[19]	new[18]|new[19]	_	_
5-15	257-260	and	abstract[18]	new[18]	_	_
5-16	261-267	spinal	abstract[18]|object[20]	new[18]|new[20]	_	_
5-17	268-272	cord	abstract[18]|object[20]	new[18]|new[20]	_	_
5-18	273-274	,	abstract[18]	new[18]	_	_
5-19	275-285	especially	abstract[18]	new[18]	_	_
5-20	286-291	spina	abstract[18]	new[18]	_	_
5-21	292-298	bifida	abstract[18]	new[18]	_	_
5-22	299-300	,	_	_	_	_
5-23	301-304	and	_	_	_	_
5-24	305-314	decreases	_	_	_	_
5-25	315-320	serum	substance|abstract[23]	new|new[23]	coref	21-16
5-26	321-333	homocysteine	abstract|abstract[23]	new|new[23]	_	_
5-27	334-340	levels	abstract[23]	new[23]	_	_
5-28	341-342	,	_	_	_	_
5-29	343-351	reducing	_	_	_	_
5-30	352-355	the	abstract[24]	new[24]	_	_
5-31	356-360	risk	abstract[24]	new[24]	_	_
5-32	361-363	of	abstract[24]	new[24]	_	_
5-33	364-369	heart	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
5-34	370-378	diseases	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
5-35	379-380	.	_	_	_	_

#Text=FA is an essential vitamin that is nowadays prescribed to pregnant women and is indicated in the prevention of certain types of anemia .
6-1	381-383	FA	substance	giv	coref	6-3[27_0]
6-2	384-386	is	_	_	_	_
6-3	387-389	an	substance[27]	giv[27]	coref	7-1[0_27]
6-4	390-399	essential	substance[27]	giv[27]	_	_
6-5	400-407	vitamin	substance[27]	giv[27]	_	_
6-6	408-412	that	_	_	_	_
6-7	413-415	is	_	_	_	_
6-8	416-424	nowadays	_	_	_	_
6-9	425-435	prescribed	_	_	_	_
6-10	436-438	to	_	_	_	_
6-11	439-447	pregnant	person[28]	new[28]	_	_
6-12	448-453	women	person[28]	new[28]	_	_
6-13	454-457	and	_	_	_	_
6-14	458-460	is	_	_	_	_
6-15	461-470	indicated	_	_	_	_
6-16	471-473	in	_	_	_	_
6-17	474-477	the	event[29]	new[29]	_	_
6-18	478-488	prevention	event[29]	new[29]	_	_
6-19	489-491	of	event[29]	new[29]	_	_
6-20	492-499	certain	event[29]|abstract[30]	new[29]|new[30]	_	_
6-21	500-505	types	event[29]|abstract[30]	new[29]|new[30]	_	_
6-22	506-508	of	event[29]|abstract[30]	new[29]|new[30]	_	_
6-23	509-515	anemia	event[29]|abstract[30]|abstract	new[29]|new[30]|new	_	_
6-24	516-517	.	_	_	_	_

#Text=FA is also used in bioimaging as an element of orientation toward cancer cells , as folate receptors are highly over-expressed on the surface of many tumors .
7-1	518-520	FA	substance	giv	coref	8-1
7-2	521-523	is	_	_	_	_
7-3	524-528	also	_	_	_	_
7-4	529-533	used	_	_	_	_
7-5	534-536	in	_	_	_	_
7-6	537-547	bioimaging	_	_	_	_
7-7	548-550	as	_	_	_	_
7-8	551-553	an	_	_	_	_
7-9	554-561	element	_	_	_	_
7-10	562-564	of	_	_	_	_
7-11	565-576	orientation	abstract[33]	new[33]	_	_
7-12	577-583	toward	abstract[33]	new[33]	_	_
7-13	584-590	cancer	abstract[33]|abstract|object[35]	new[33]|new|new[35]	_	_
7-14	591-596	cells	abstract[33]|object[35]	new[33]|new[35]	_	_
7-15	597-598	,	_	_	_	_
7-16	599-601	as	_	_	_	_
7-17	602-608	folate	substance|substance[37]	new|new[37]	_	_
7-18	609-618	receptors	substance[37]	new[37]	_	_
7-19	619-622	are	_	_	_	_
7-20	623-629	highly	_	_	_	_
7-21	630-644	over-expressed	_	_	_	_
7-22	645-647	on	_	_	_	_
7-23	648-651	the	place[38]	new[38]	_	_
7-24	652-659	surface	place[38]	new[38]	_	_
7-25	660-662	of	place[38]	new[38]	_	_
7-26	663-667	many	place[38]|object[39]	new[38]|new[39]	_	_
7-27	668-674	tumors	place[38]|object[39]	new[38]|new[39]	_	_
7-28	675-676	.	_	_	_	_

#Text=FA plays an important role in the proper development of physiological processes in the body .
8-1	677-679	FA	substance	giv	coref	9-9
8-2	680-685	plays	_	_	_	_
8-3	686-688	an	abstract[41]	new[41]	_	_
8-4	689-698	important	abstract[41]	new[41]	_	_
8-5	699-703	role	abstract[41]	new[41]	_	_
8-6	704-706	in	_	_	_	_
8-7	707-710	the	abstract[42]	new[42]	_	_
8-8	711-717	proper	abstract[42]	new[42]	_	_
8-9	718-729	development	abstract[42]	new[42]	_	_
8-10	730-732	of	abstract[42]	new[42]	_	_
8-11	733-746	physiological	abstract[42]|abstract[43]	new[42]|new[43]	_	_
8-12	747-756	processes	abstract[42]|abstract[43]	new[42]|new[43]	_	_
8-13	757-759	in	abstract[42]|abstract[43]	new[42]|new[43]	_	_
8-14	760-763	the	abstract[42]|abstract[43]|object[44]	new[42]|new[43]|new[44]	coref	9-1[45_44]
8-15	764-768	body	abstract[42]|abstract[43]|object[44]	new[42]|new[43]|new[44]	_	_
8-16	769-770	.	_	_	_	_

#Text=The human body is not able to synthesize FA , and its presence in foods such as spinach , cereals , citrus , rice , and beans may not be enough to meet the daily requirement for this vitamin .
9-1	771-774	The	object[45]	giv[45]	_	_
9-2	775-780	human	object[45]	giv[45]	_	_
9-3	781-785	body	object[45]	giv[45]	_	_
9-4	786-788	is	_	_	_	_
9-5	789-792	not	_	_	_	_
9-6	793-797	able	_	_	_	_
9-7	798-800	to	_	_	_	_
9-8	801-811	synthesize	_	_	_	_
9-9	812-814	FA	abstract	giv	ana	9-12
9-10	815-816	,	_	_	_	_
9-11	817-820	and	_	_	_	_
9-12	821-824	its	substance|abstract[48]	giv|new[48]	coref	9-38[56_0]
9-13	825-833	presence	abstract[48]	new[48]	_	_
9-14	834-836	in	abstract[48]	new[48]	_	_
9-15	837-842	foods	abstract[48]|substance[49]	new[48]|new[49]	coref	10-5[0_49]
9-16	843-847	such	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-17	848-850	as	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-18	851-858	spinach	abstract[48]|substance[49]|plant	new[48]|new[49]|new	_	_
9-19	859-860	,	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-20	861-868	cereals	abstract[48]|substance[49]|plant	new[48]|new[49]|new	_	_
9-21	869-870	,	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-22	871-877	citrus	abstract[48]|substance[49]|plant	new[48]|new[49]|new	_	_
9-23	878-879	,	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-24	880-884	rice	abstract[48]|substance[49]|substance	new[48]|new[49]|new	_	_
9-25	885-886	,	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-26	887-890	and	abstract[48]|substance[49]	new[48]|new[49]	_	_
9-27	891-896	beans	abstract[48]|substance[49]|plant	new[48]|new[49]|new	_	_
9-28	897-900	may	_	_	_	_
9-29	901-904	not	_	_	_	_
9-30	905-907	be	_	_	_	_
9-31	908-914	enough	_	_	_	_
9-32	915-917	to	_	_	_	_
9-33	918-922	meet	_	_	_	_
9-34	923-926	the	abstract[55]	new[55]	_	_
9-35	927-932	daily	abstract[55]	new[55]	_	_
9-36	933-944	requirement	abstract[55]	new[55]	_	_
9-37	945-948	for	abstract[55]	new[55]	_	_
9-38	949-953	this	abstract[55]|substance[56]	new[55]|giv[56]	coref	10-8[59_56]
9-39	954-961	vitamin	abstract[55]|substance[56]	new[55]|giv[56]	_	_
9-40	962-963	.	_	_	_	_

#Text=The daily consumption of foods fortified with FA , such as citrus beverages , can provide the amount required for human health .
10-1	964-967	The	abstract[57]	new[57]	_	_
10-2	968-973	daily	abstract[57]	new[57]	_	_
10-3	974-985	consumption	abstract[57]	new[57]	_	_
10-4	986-988	of	abstract[57]	new[57]	_	_
10-5	989-994	foods	abstract[57]|substance	new[57]|giv	_	_
10-6	995-1004	fortified	_	_	_	_
10-7	1005-1009	with	_	_	_	_
10-8	1010-1012	FA	abstract[59]	giv[59]	coref	11-11[0_59]
10-9	1013-1014	,	abstract[59]	giv[59]	_	_
10-10	1015-1019	such	abstract[59]	giv[59]	_	_
10-11	1020-1022	as	abstract[59]	giv[59]	_	_
10-12	1023-1029	citrus	abstract[59]|substance[60]	giv[59]|new[60]	coref	11-13[65_60]
10-13	1030-1039	beverages	abstract[59]|substance[60]	giv[59]|new[60]	_	_
10-14	1040-1041	,	_	_	_	_
10-15	1042-1045	can	_	_	_	_
10-16	1046-1053	provide	_	_	_	_
10-17	1054-1057	the	quantity[61]	new[61]	_	_
10-18	1058-1064	amount	quantity[61]	new[61]	_	_
10-19	1065-1073	required	_	_	_	_
10-20	1074-1077	for	_	_	_	_
10-21	1078-1083	human	abstract[62]	new[62]	_	_
10-22	1084-1090	health	abstract[62]	new[62]	_	_
10-23	1091-1092	.	_	_	_	_

#Text=Therefore , having a simple and fast method for determining FA in commercial beverages is of great interest .
11-1	1093-1102	Therefore	_	_	_	_
11-2	1103-1104	,	_	_	_	_
11-3	1105-1111	having	_	_	_	_
11-4	1112-1113	a	abstract[63]	new[63]	coref	15-6[88_63]
11-5	1114-1120	simple	abstract[63]	new[63]	_	_
11-6	1121-1124	and	abstract[63]	new[63]	_	_
11-7	1125-1129	fast	abstract[63]	new[63]	_	_
11-8	1130-1136	method	abstract[63]	new[63]	_	_
11-9	1137-1140	for	_	_	_	_
11-10	1141-1152	determining	_	_	_	_
11-11	1153-1155	FA	substance	giv	coref	12-13
11-12	1156-1158	in	_	_	_	_
11-13	1159-1169	commercial	substance[65]	giv[65]	coref	30-31[217_65]
11-14	1170-1179	beverages	substance[65]	giv[65]	_	_
11-15	1180-1182	is	_	_	_	_
11-16	1183-1185	of	_	_	_	_
11-17	1186-1191	great	abstract[66]	new[66]	_	_
11-18	1192-1200	interest	abstract[66]	new[66]	_	_
11-19	1201-1202	.	_	_	_	_

#Text=Different methods have been reported in the literature for the quantification of FA , including spectrophotometric methods , electrochemical techniques , high-performance liquid chromatography ( HPLC ) and ultrahigh HPLC , and ion chromatography .
12-1	1203-1212	Different	abstract[67]	new[67]	coref	12-16[71_67]
12-2	1213-1220	methods	abstract[67]	new[67]	_	_
12-3	1221-1225	have	_	_	_	_
12-4	1226-1230	been	_	_	_	_
12-5	1231-1239	reported	_	_	_	_
12-6	1240-1242	in	_	_	_	_
12-7	1243-1246	the	abstract[68]	new[68]	_	_
12-8	1247-1257	literature	abstract[68]	new[68]	_	_
12-9	1258-1261	for	abstract[68]	new[68]	_	_
12-10	1262-1265	the	abstract[68]|abstract[69]	new[68]|new[69]	_	_
12-11	1266-1280	quantification	abstract[68]|abstract[69]	new[68]|new[69]	_	_
12-12	1281-1283	of	abstract[68]|abstract[69]	new[68]|new[69]	_	_
12-13	1284-1286	FA	abstract[68]|abstract[69]|substance	new[68]|new[69]|giv	coref	15-23
12-14	1287-1288	,	abstract[68]|abstract[69]	new[68]|new[69]	_	_
12-15	1289-1298	including	abstract[68]|abstract[69]	new[68]|new[69]	_	_
12-16	1299-1317	spectrophotometric	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	coref	13-4[79_71]
12-17	1318-1325	methods	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-18	1326-1327	,	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-19	1328-1343	electrochemical	abstract[68]|abstract[69]|abstract[71]|abstract[72]	new[68]|new[69]|giv[71]|new[72]	_	_
12-20	1344-1354	techniques	abstract[68]|abstract[69]|abstract[71]|abstract[72]	new[68]|new[69]|giv[71]|new[72]	_	_
12-21	1355-1356	,	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-22	1357-1373	high-performance	abstract[68]|abstract[69]|abstract[71]|abstract[74]	new[68]|new[69]|giv[71]|new[74]	_	_
12-23	1374-1380	liquid	abstract[68]|abstract[69]|abstract[71]|substance|abstract[74]	new[68]|new[69]|giv[71]|new|new[74]	_	_
12-24	1381-1395	chromatography	abstract[68]|abstract[69]|abstract[71]|abstract[74]	new[68]|new[69]|giv[71]|new[74]	_	_
12-25	1396-1397	(	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-26	1398-1402	HPLC	abstract[68]|abstract[69]|abstract[71]|object	new[68]|new[69]|giv[71]|new	coref	12-29[76_0]
12-27	1403-1404	)	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-28	1405-1408	and	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-29	1409-1418	ultrahigh	abstract[68]|abstract[69]|abstract[71]|object[76]	new[68]|new[69]|giv[71]|giv[76]	_	_
12-30	1419-1423	HPLC	abstract[68]|abstract[69]|abstract[71]|object[76]	new[68]|new[69]|giv[71]|giv[76]	_	_
12-31	1424-1425	,	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-32	1426-1429	and	abstract[68]|abstract[69]|abstract[71]	new[68]|new[69]|giv[71]	_	_
12-33	1430-1433	ion	abstract[68]|abstract[69]|abstract[71]|abstract|object[78]	new[68]|new[69]|giv[71]|new|new[78]	_	_
12-34	1434-1448	chromatography	abstract[68]|abstract[69]|abstract[71]|object[78]	new[68]|new[69]|giv[71]|new[78]	_	_
12-35	1449-1450	.	_	_	_	_

#Text=In general , these methods are based on time-consuming reactions that involve laborious and slow procedures .
13-1	1451-1453	In	_	_	_	_
13-2	1454-1461	general	_	_	_	_
13-3	1462-1463	,	_	_	_	_
13-4	1464-1469	these	abstract[79]	giv[79]	coref	14-4[82_79]
13-5	1470-1477	methods	abstract[79]	giv[79]	_	_
13-6	1478-1481	are	_	_	_	_
13-7	1482-1487	based	_	_	_	_
13-8	1488-1490	on	_	_	_	_
13-9	1491-1505	time-consuming	abstract[80]	new[80]	_	_
13-10	1506-1515	reactions	abstract[80]	new[80]	_	_
13-11	1516-1520	that	_	_	_	_
13-12	1521-1528	involve	_	_	_	_
13-13	1529-1538	laborious	abstract[81]	new[81]	_	_
13-14	1539-1542	and	abstract[81]	new[81]	_	_
13-15	1543-1547	slow	abstract[81]	new[81]	_	_
13-16	1548-1558	procedures	abstract[81]	new[81]	_	_
13-17	1559-1560	.	_	_	_	_

#Text=In particular , the chromatographic methods require expensive equipment and the use of large volumes of organic solvents .
14-1	1561-1563	In	_	_	_	_
14-2	1564-1574	particular	_	_	_	_
14-3	1575-1576	,	_	_	_	_
14-4	1577-1580	the	abstract[82]	giv[82]	coref	16-1[97_82]
14-5	1581-1596	chromatographic	abstract[82]	giv[82]	_	_
14-6	1597-1604	methods	abstract[82]	giv[82]	_	_
14-7	1605-1612	require	_	_	_	_
14-8	1613-1622	expensive	object[83]	new[83]	_	_
14-9	1623-1632	equipment	object[83]	new[83]	_	_
14-10	1633-1636	and	_	_	_	_
14-11	1637-1640	the	abstract[84]	new[84]	_	_
14-12	1641-1644	use	abstract[84]	new[84]	_	_
14-13	1645-1647	of	abstract[84]	new[84]	_	_
14-14	1648-1653	large	abstract[84]|abstract[85]	new[84]|new[85]	_	_
14-15	1654-1661	volumes	abstract[84]|abstract[85]	new[84]|new[85]	_	_
14-16	1662-1664	of	abstract[84]|abstract[85]	new[84]|new[85]	_	_
14-17	1665-1672	organic	abstract[84]|abstract[85]|substance[86]	new[84]|new[85]|new[86]	_	_
14-18	1673-1681	solvents	abstract[84]|abstract[85]|substance[86]	new[84]|new[85]|new[86]	_	_
14-19	1682-1683	.	_	_	_	_

#Text=Therefore , the development of a simple , accurate , and low-cost method with high sensitivity and selectivity for the determination of FA is of great importance for monitoring the quality of food products .
15-1	1684-1693	Therefore	_	_	_	_
15-2	1694-1695	,	_	_	_	_
15-3	1696-1699	the	abstract[87]	new[87]	_	_
15-4	1700-1711	development	abstract[87]	new[87]	_	_
15-5	1712-1714	of	abstract[87]	new[87]	_	_
15-6	1715-1716	a	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-7	1717-1723	simple	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-8	1724-1725	,	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-9	1726-1734	accurate	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-10	1735-1736	,	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-11	1737-1740	and	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-12	1741-1749	low-cost	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-13	1750-1756	method	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-14	1757-1761	with	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-15	1762-1766	high	abstract[87]|abstract[88]|abstract[89]	new[87]|giv[88]|new[89]	coref	16-16[0_89]
15-16	1767-1778	sensitivity	abstract[87]|abstract[88]|abstract[89]	new[87]|giv[88]|new[89]	_	_
15-17	1779-1782	and	abstract[87]|abstract[88]	new[87]|giv[88]	_	_
15-18	1783-1794	selectivity	abstract[87]|abstract[88]|abstract[90]	new[87]|giv[88]|new[90]	coref	16-13[101_90]
15-19	1795-1798	for	abstract[87]|abstract[88]|abstract[90]	new[87]|giv[88]|new[90]	_	_
15-20	1799-1802	the	abstract[87]|abstract[88]|abstract[90]|abstract[91]	new[87]|giv[88]|new[90]|new[91]	coref	20-7[123_91]
15-21	1803-1816	determination	abstract[87]|abstract[88]|abstract[90]|abstract[91]	new[87]|giv[88]|new[90]|new[91]	_	_
15-22	1817-1819	of	abstract[87]|abstract[88]|abstract[90]|abstract[91]	new[87]|giv[88]|new[90]|new[91]	_	_
15-23	1820-1822	FA	abstract[87]|abstract[88]|abstract[90]|abstract[91]|substance	new[87]|giv[88]|new[90]|new[91]|giv	coref	20-10
15-24	1823-1825	is	_	_	_	_
15-25	1826-1828	of	_	_	_	_
15-26	1829-1834	great	abstract[93]	new[93]	_	_
15-27	1835-1845	importance	abstract[93]	new[93]	_	_
15-28	1846-1849	for	_	_	_	_
15-29	1850-1860	monitoring	_	_	_	_
15-30	1861-1864	the	abstract[94]	new[94]	_	_
15-31	1865-1872	quality	abstract[94]	new[94]	_	_
15-32	1873-1875	of	abstract[94]	new[94]	_	_
15-33	1876-1880	food	abstract[94]|substance[95]	new[94]|new[95]	_	_
15-34	1881-1889	products	abstract[94]|substance[95]	new[94]|new[95]	_	_
15-35	1890-1891	.	_	_	_	_

#Text=Fluorescence methods have gained considerable attention in recent years , due to their selectivity , sensitivity , easy sample preparation , and rapid analysis .
16-1	1892-1904	Fluorescence	abstract|abstract[97]	new|giv[97]	ana|coref	16-13[0_97]|21-23
16-2	1905-1912	methods	abstract[97]	giv[97]	_	_
16-3	1913-1917	have	_	_	_	_
16-4	1918-1924	gained	_	_	_	_
16-5	1925-1937	considerable	abstract[98]	new[98]	_	_
16-6	1938-1947	attention	abstract[98]	new[98]	_	_
16-7	1948-1950	in	_	_	_	_
16-8	1951-1957	recent	time[99]	new[99]	coref	20-2[121_99]
16-9	1958-1963	years	time[99]	new[99]	_	_
16-10	1964-1965	,	_	_	_	_
16-11	1966-1969	due	_	_	_	_
16-12	1970-1972	to	_	_	_	_
16-13	1973-1978	their	abstract|abstract[101]	giv|giv[101]	coref	20-5[122_0]
16-14	1979-1990	selectivity	abstract[101]	giv[101]	_	_
16-15	1991-1992	,	_	_	_	_
16-16	1993-2004	sensitivity	abstract	giv	_	_
16-17	2005-2006	,	_	_	_	_
16-18	2007-2011	easy	abstract[103]	new[103]	_	_
16-19	2012-2018	sample	abstract[103]	new[103]	_	_
16-20	2019-2030	preparation	abstract[103]	new[103]	_	_
16-21	2031-2032	,	_	_	_	_
16-22	2033-2036	and	_	_	_	_
16-23	2037-2042	rapid	abstract[104]	new[104]	_	_
16-24	2043-2051	analysis	abstract[104]	new[104]	_	_
16-25	2052-2053	.	_	_	_	_

#Text=As a kind of new fluorophore , quantum dots ( QDs ) are a favorable alternative as they have advantages over conventional organic fluorescent dyes .
17-1	2054-2056	As	_	_	_	_
17-2	2057-2058	a	_	_	_	_
17-3	2059-2063	kind	abstract[105]|abstract[106]	new[105]|new[106]	ana	17-18[0_106]
17-4	2064-2066	of	abstract[105]|abstract[106]	new[105]|new[106]	_	_
17-5	2067-2070	new	abstract[105]|abstract[106]	new[105]|new[106]	_	_
17-6	2071-2082	fluorophore	abstract[105]|abstract[106]	new[105]|new[106]	_	_
17-7	2083-2084	,	abstract[106]	new[106]	_	_
17-8	2085-2092	quantum	abstract[106]|object[107]	new[106]|new[107]	_	_
17-9	2093-2097	dots	abstract[106]|object[107]	new[106]|new[107]	_	_
17-10	2098-2099	(	_	_	_	_
17-11	2100-2103	QDs	abstract	new	coref	19-1
17-12	2104-2105	)	_	_	_	_
17-13	2106-2109	are	_	_	_	_
17-14	2110-2111	a	abstract[109]	new[109]	_	_
17-15	2112-2121	favorable	abstract[109]	new[109]	_	_
17-16	2122-2133	alternative	abstract[109]	new[109]	_	_
17-17	2134-2136	as	_	_	_	_
17-18	2137-2141	they	abstract	giv	_	_
17-19	2142-2146	have	_	_	_	_
17-20	2147-2157	advantages	abstract[111]	new[111]	ana	18-1[0_111]
17-21	2158-2162	over	abstract[111]	new[111]	_	_
17-22	2163-2175	conventional	abstract[111]|object[112]	new[111]|new[112]	_	_
17-23	2176-2183	organic	abstract[111]|object[112]	new[111]|new[112]	_	_
17-24	2184-2195	fluorescent	abstract[111]|object[112]	new[111]|new[112]	_	_
17-25	2196-2200	dyes	abstract[111]|object[112]	new[111]|new[112]	_	_
17-26	2201-2202	.	_	_	_	_

#Text=They have unusual optical and electronic properties as a consequence of the quantum confinement effect .
18-1	2203-2207	They	abstract	giv	_	_
18-2	2208-2212	have	_	_	_	_
18-3	2213-2220	unusual	abstract[114]	new[114]	_	_
18-4	2221-2228	optical	abstract[114]	new[114]	_	_
18-5	2229-2232	and	abstract[114]	new[114]	_	_
18-6	2233-2243	electronic	abstract[114]	new[114]	_	_
18-7	2244-2254	properties	abstract[114]	new[114]	_	_
18-8	2255-2257	as	_	_	_	_
18-9	2258-2259	a	_	_	_	_
18-10	2260-2271	consequence	_	_	_	_
18-11	2272-2274	of	_	_	_	_
18-12	2275-2278	the	abstract[116]	new[116]	_	_
18-13	2279-2286	quantum	abstract[116]	new[116]	_	_
18-14	2287-2298	confinement	abstract|abstract[116]	new|new[116]	_	_
18-15	2299-2305	effect	abstract[116]	new[116]	_	_
18-16	2306-2307	.	_	_	_	_

#Text=QDs have been proven to be effective in different applications as biological biomarkers , sensors , drug delivery systems , and solar cells .
19-1	2308-2311	QDs	abstract	giv	coref	22-9
19-2	2312-2316	have	_	_	_	_
19-3	2317-2321	been	_	_	_	_
19-4	2322-2328	proven	_	_	_	_
19-5	2329-2331	to	_	_	_	_
19-6	2332-2334	be	_	_	_	_
19-7	2335-2344	effective	_	_	_	_
19-8	2345-2347	in	_	_	_	_
19-9	2348-2357	different	abstract[118]	new[118]	_	_
19-10	2358-2370	applications	abstract[118]	new[118]	_	_
19-11	2371-2373	as	abstract[118]	new[118]	_	_
19-12	2374-2384	biological	abstract[118]	new[118]	_	_
19-13	2385-2395	biomarkers	abstract[118]	new[118]	_	_
19-14	2396-2397	,	abstract[118]	new[118]	_	_
19-15	2398-2405	sensors	abstract[118]	new[118]	_	_
19-16	2406-2407	,	abstract[118]	new[118]	_	_
19-17	2408-2412	drug	abstract[118]|substance	new[118]|new	_	_
19-18	2413-2421	delivery	abstract[118]|abstract	new[118]|new	_	_
19-19	2422-2429	systems	abstract[118]	new[118]	_	_
19-20	2430-2431	,	abstract[118]	new[118]	_	_
19-21	2432-2435	and	abstract[118]	new[118]	_	_
19-22	2436-2441	solar	abstract[118]	new[118]	_	_
19-23	2442-2447	cells	abstract[118]	new[118]	_	_
19-24	2448-2449	.	_	_	_	_

#Text=In recent years , methods for the determination of FA based on the use of nanomaterials have been reported .
20-1	2450-2452	In	_	_	_	_
20-2	2453-2459	recent	time[121]	giv[121]	_	_
20-3	2460-2465	years	time[121]	giv[121]	_	_
20-4	2466-2467	,	_	_	_	_
20-5	2468-2475	methods	abstract[122]	giv[122]	_	_
20-6	2476-2479	for	abstract[122]	giv[122]	_	_
20-7	2480-2483	the	abstract[122]|abstract[123]	giv[122]|giv[123]	coref	21-40[146_123]
20-8	2484-2497	determination	abstract[122]|abstract[123]	giv[122]|giv[123]	_	_
20-9	2498-2500	of	abstract[122]|abstract[123]	giv[122]|giv[123]	_	_
20-10	2501-2503	FA	abstract[122]|abstract[123]|substance	giv[122]|giv[123]|giv	coref	21-43
20-11	2504-2509	based	_	_	_	_
20-12	2510-2512	on	_	_	_	_
20-13	2513-2516	the	abstract[125]	new[125]	_	_
20-14	2517-2520	use	abstract[125]	new[125]	_	_
20-15	2521-2523	of	abstract[125]	new[125]	_	_
20-16	2524-2537	nanomaterials	abstract[125]|object	new[125]|new	_	_
20-17	2538-2542	have	_	_	_	_
20-18	2543-2547	been	_	_	_	_
20-19	2548-2556	reported	_	_	_	_
20-20	2557-2558	.	_	_	_	_

#Text=Graphene oxide/Ag nanoparticle hybrids with surface-enhanced Raman spectroscopy ( SERS ) detection , a bovine serum albumin ( BSA)-modified gold nanocluster with fluorescence detection , and a ZrO2 nanoparticle-modified carbon paste electrode with voltammetry detection have been used in the determination of FA .
21-1	2559-2567	Graphene	animal|object[130]	new|new[130]	_	_
21-2	2568-2576	oxide/Ag	animal|object[130]	new|new[130]	_	_
21-3	2577-2589	nanoparticle	quantity|object[130]	new|new[130]	_	_
21-4	2590-2597	hybrids	object[130]	new[130]	_	_
21-5	2598-2602	with	object[130]	new[130]	_	_
21-6	2603-2619	surface-enhanced	object[130]|abstract[131]	new[130]|new[131]	appos	21-10[0_131]
21-7	2620-2625	Raman	object[130]|abstract[131]	new[130]|new[131]	_	_
21-8	2626-2638	spectroscopy	object[130]|abstract[131]	new[130]|new[131]	_	_
21-9	2639-2640	(	object[130]	new[130]	_	_
21-10	2641-2645	SERS	object[130]|abstract	new[130]|giv	coref	33-12[234_0]
21-11	2646-2647	)	object[130]	new[130]	_	_
21-12	2648-2657	detection	object[130]|abstract	new[130]|new	coref	21-23[140_0]
21-13	2658-2659	,	object[130]	new[130]	_	_
21-14	2660-2661	a	object[130]|object[136]	new[130]|new[136]	appos	21-19[138_136]
21-15	2662-2668	bovine	object[130]|place|object[136]	new[130]|new|new[136]	_	_
21-16	2669-2674	serum	object[130]|abstract|object[136]	new[130]|giv|new[136]	_	_
21-17	2675-2682	albumin	object[130]|object[136]	new[130]|new[136]	_	_
21-18	2683-2684	(	object[130]	new[130]	_	_
21-19	2685-2698	BSA)-modified	object[130]|object[138]	new[130]|giv[138]	_	_
21-20	2699-2703	gold	object[130]|substance|object[138]	new[130]|new|giv[138]	_	_
21-21	2704-2715	nanocluster	object[130]|object[138]	new[130]|giv[138]	_	_
21-22	2716-2720	with	object[130]|object[138]	new[130]|giv[138]	_	_
21-23	2721-2733	fluorescence	object[130]|object[138]|abstract|abstract[140]	new[130]|giv[138]|giv|giv[140]	coref|coref	21-34[145_140]|33-22
21-24	2734-2743	detection	object[130]|object[138]|abstract[140]	new[130]|giv[138]|giv[140]	_	_
21-25	2744-2745	,	object[130]	new[130]	_	_
21-26	2746-2749	and	object[130]	new[130]	_	_
21-27	2750-2751	a	object[130]|object[143]	new[130]|new[143]	_	_
21-28	2752-2756	ZrO2	object[130]|abstract|object[143]	new[130]|new|new[143]	_	_
21-29	2757-2778	nanoparticle-modified	object[130]|object[143]	new[130]|new[143]	_	_
21-30	2779-2785	carbon	object[130]|object[143]	new[130]|new[143]	_	_
21-31	2786-2791	paste	object[130]|abstract|object[143]	new[130]|new|new[143]	_	_
21-32	2792-2801	electrode	object[130]|object[143]	new[130]|new[143]	_	_
21-33	2802-2806	with	object[130]|object[143]	new[130]|new[143]	_	_
21-34	2807-2818	voltammetry	object[130]|object[143]|abstract|abstract[145]	new[130]|new[143]|new|giv[145]	coref	39-14[0_145]
21-35	2819-2828	detection	object[130]|object[143]|abstract[145]	new[130]|new[143]|giv[145]	_	_
21-36	2829-2833	have	_	_	_	_
21-37	2834-2838	been	_	_	_	_
21-38	2839-2843	used	_	_	_	_
21-39	2844-2846	in	_	_	_	_
21-40	2847-2850	the	abstract[146]	giv[146]	coref	22-4[149_146]
21-41	2851-2864	determination	abstract[146]	giv[146]	_	_
21-42	2865-2867	of	abstract[146]	giv[146]	_	_
21-43	2868-2870	FA	abstract[146]|abstract	giv[146]|giv	coref	22-7
21-44	2871-2872	.	_	_	_	_

#Text=Other works show the determination of FA using QDs capped with thiolated ligands as thioglycolic ( TGA ) and mercaptopropionic ( MPA ) acids .
22-1	2873-2878	Other	abstract[148]	new[148]	coref	28-3[195_148]
22-2	2879-2884	works	abstract[148]	new[148]	_	_
22-3	2885-2889	show	_	_	_	_
22-4	2890-2893	the	abstract[149]	giv[149]	coref	29-16[204_149]
22-5	2894-2907	determination	abstract[149]	giv[149]	_	_
22-6	2908-2910	of	abstract[149]	giv[149]	_	_
22-7	2911-2913	FA	abstract[149]|object	giv[149]|giv	coref	24-5
22-8	2914-2919	using	_	_	_	_
22-9	2920-2923	QDs	abstract	giv	coref	23-25[162_0]
22-10	2924-2930	capped	_	_	_	_
22-11	2931-2935	with	_	_	_	_
22-12	2936-2945	thiolated	substance[152]	new[152]	_	_
22-13	2946-2953	ligands	substance[152]	new[152]	_	_
22-14	2954-2956	as	substance[152]	new[152]	_	_
22-15	2957-2969	thioglycolic	substance[152]	new[152]	_	_
22-16	2970-2971	(	_	_	_	_
22-17	2972-2975	TGA	abstract	new	_	_
22-18	2976-2977	)	_	_	_	_
22-19	2978-2981	and	_	_	_	_
22-20	2982-2999	mercaptopropionic	_	_	_	_
22-21	3000-3001	(	_	_	_	_
22-22	3002-3005	MPA	object	new	_	_
22-23	3006-3007	)	_	_	_	_
22-24	3008-3013	acids	substance	new	_	_
22-25	3014-3015	.	_	_	_	_

#Text=However , in these nanoparticles , at pH 8 , the carboxylate groups are dissociated , giving a negative charge to the surface of the QDs .
23-1	3016-3023	However	_	_	_	_
23-2	3024-3025	,	_	_	_	_
23-3	3026-3028	in	_	_	_	_
23-4	3029-3034	these	object[156]	new[156]	_	_
23-5	3035-3048	nanoparticles	object[156]	new[156]	_	_
23-6	3049-3050	,	_	_	_	_
23-7	3051-3053	at	_	_	_	_
23-8	3054-3056	pH	quantity[157]	new[157]	coref	25-12[172_157]
23-9	3057-3058	8	quantity[157]	new[157]	_	_
23-10	3059-3060	,	_	_	_	_
23-11	3061-3064	the	person[159]	new[159]	coref	25-6[171_159]
23-12	3065-3076	carboxylate	object|person[159]	new|new[159]	_	_
23-13	3077-3083	groups	person[159]	new[159]	_	_
23-14	3084-3087	are	_	_	_	_
23-15	3088-3099	dissociated	_	_	_	_
23-16	3100-3101	,	_	_	_	_
23-17	3102-3108	giving	_	_	_	_
23-18	3109-3110	a	abstract[160]	new[160]	_	_
23-19	3111-3119	negative	abstract[160]	new[160]	_	_
23-20	3120-3126	charge	abstract[160]	new[160]	_	_
23-21	3127-3129	to	_	_	_	_
23-22	3130-3133	the	place[161]	new[161]	_	_
23-23	3134-3141	surface	place[161]	new[161]	_	_
23-24	3142-3144	of	place[161]	new[161]	_	_
23-25	3145-3148	the	place[161]|abstract[162]	new[161]|giv[162]	coref	24-15[166_162]
23-26	3149-3152	QDs	place[161]|abstract[162]	new[161]|giv[162]	_	_
23-27	3153-3154	.	_	_	_	_

#Text=Under these conditions , FA is also negatively charged , and the interaction between the QDs and FA is not favored , due to electrostatic repulsions .
24-1	3155-3160	Under	_	_	_	_
24-2	3161-3166	these	abstract[163]	new[163]	_	_
24-3	3167-3177	conditions	abstract[163]	new[163]	_	_
24-4	3178-3179	,	_	_	_	_
24-5	3180-3182	FA	substance	giv	coref	24-18
24-6	3183-3185	is	_	_	_	_
24-7	3186-3190	also	_	_	_	_
24-8	3191-3201	negatively	_	_	_	_
24-9	3202-3209	charged	_	_	_	_
24-10	3210-3211	,	_	_	_	_
24-11	3212-3215	and	_	_	_	_
24-12	3216-3219	the	abstract[165]	new[165]	_	_
24-13	3220-3231	interaction	abstract[165]	new[165]	_	_
24-14	3232-3239	between	abstract[165]	new[165]	_	_
24-15	3240-3243	the	abstract[165]|abstract[166]	new[165]|giv[166]	coref	25-3[0_166]
24-16	3244-3247	QDs	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
24-17	3248-3251	and	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
24-18	3252-3254	FA	abstract[165]|abstract[166]|substance	new[165]|giv[166]|giv	coref	29-19
24-19	3255-3257	is	_	_	_	_
24-20	3258-3261	not	_	_	_	_
24-21	3262-3269	favored	_	_	_	_
24-22	3270-3271	,	_	_	_	_
24-23	3272-3275	due	_	_	_	_
24-24	3276-3278	to	_	_	_	_
24-25	3279-3292	electrostatic	abstract[168]	new[168]	_	_
24-26	3293-3303	repulsions	abstract[168]	new[168]	_	_
24-27	3304-3305	.	_	_	_	_

#Text=Therefore , QDs coated with amino groups , which , at pH 8 , are positively charged , could improve the analytical characteristics of the sensor .
25-1	3306-3315	Therefore	_	_	_	_
25-2	3316-3317	,	_	_	_	_
25-3	3318-3321	QDs	event	giv	coref	26-23[183_0]
25-4	3322-3328	coated	_	_	_	_
25-5	3329-3333	with	_	_	_	_
25-6	3334-3339	amino	object|person[171]	new|giv[171]	coref|coref	26-11[179_171]|26-26
25-7	3340-3346	groups	person[171]	giv[171]	_	_
25-8	3347-3348	,	_	_	_	_
25-9	3349-3354	which	_	_	_	_
25-10	3355-3356	,	_	_	_	_
25-11	3357-3359	at	_	_	_	_
25-12	3360-3362	pH	abstract[172]	giv[172]	coref	27-12[190_172]
25-13	3363-3364	8	abstract[172]	giv[172]	_	_
25-14	3365-3366	,	_	_	_	_
25-15	3367-3370	are	_	_	_	_
25-16	3371-3381	positively	_	_	_	_
25-17	3382-3389	charged	_	_	_	_
25-18	3390-3391	,	_	_	_	_
25-19	3392-3397	could	_	_	_	_
25-20	3398-3405	improve	_	_	_	_
25-21	3406-3409	the	abstract[173]	new[173]	coref	31-6[219_173]
25-22	3410-3420	analytical	abstract[173]	new[173]	_	_
25-23	3421-3436	characteristics	abstract[173]	new[173]	_	_
25-24	3437-3439	of	abstract[173]	new[173]	_	_
25-25	3440-3443	the	abstract[173]|object[174]	new[173]|new[174]	coref	30-13[209_174]
25-26	3444-3450	sensor	abstract[173]|object[174]	new[173]|new[174]	_	_
25-27	3451-3452	.	_	_	_	_

#Text=Cysteamine ( CA ) is a bifunctional ligand , with thiol groups that bind strongly to metal ions on the surface of QDs and hydrophilic amino groups that render the QDs biocompatible and dispersible in water .
26-1	3453-3463	Cysteamine	substance	new	coref	26-6[177_0]
26-2	3464-3465	(	_	_	_	_
26-3	3466-3468	CA	object	new	coref	32-16
26-4	3469-3470	)	_	_	_	_
26-5	3471-3473	is	_	_	_	_
26-6	3474-3475	a	substance[177]	giv[177]	_	_
26-7	3476-3488	bifunctional	substance[177]	giv[177]	_	_
26-8	3489-3495	ligand	substance[177]	giv[177]	_	_
26-9	3496-3497	,	substance[177]	giv[177]	_	_
26-10	3498-3502	with	substance[177]	giv[177]	_	_
26-11	3503-3508	thiol	substance[177]|organization|person[179]	giv[177]|new|giv[179]	coref	26-25[185_179]
26-12	3509-3515	groups	substance[177]|person[179]	giv[177]|giv[179]	_	_
26-13	3516-3520	that	_	_	_	_
26-14	3521-3525	bind	_	_	_	_
26-15	3526-3534	strongly	_	_	_	_
26-16	3535-3537	to	_	_	_	_
26-17	3538-3543	metal	substance|substance[181]	new|new[181]	_	_
26-18	3544-3548	ions	substance[181]	new[181]	_	_
26-19	3549-3551	on	substance[181]	new[181]	_	_
26-20	3552-3555	the	substance[181]|place[182]	new[181]|new[182]	_	_
26-21	3556-3563	surface	substance[181]|place[182]	new[181]|new[182]	_	_
26-22	3564-3566	of	substance[181]|place[182]	new[181]|new[182]	_	_
26-23	3567-3570	QDs	substance[181]|place[182]|abstract[183]	new[181]|new[182]|giv[183]	coref	26-30[186_183]
26-24	3571-3574	and	substance[181]|place[182]|abstract[183]	new[181]|new[182]|giv[183]	_	_
26-25	3575-3586	hydrophilic	substance[181]|place[182]|abstract[183]|person[185]	new[181]|new[182]|giv[183]|giv[185]	coref	27-4[189_185]
26-26	3587-3592	amino	substance[181]|place[182]|abstract[183]|object|person[185]	new[181]|new[182]|giv[183]|giv|giv[185]	coref	27-5
26-27	3593-3599	groups	substance[181]|place[182]|abstract[183]|person[185]	new[181]|new[182]|giv[183]|giv[185]	_	_
26-28	3600-3604	that	_	_	_	_
26-29	3605-3611	render	_	_	_	_
26-30	3612-3615	the	abstract[186]	giv[186]	coref	28-7[196_186]
26-31	3616-3619	QDs	abstract[186]	giv[186]	_	_
26-32	3620-3633	biocompatible	abstract[186]	giv[186]	_	_
26-33	3634-3637	and	abstract[186]	giv[186]	_	_
26-34	3638-3649	dispersible	abstract[186]	giv[186]	_	_
26-35	3650-3652	in	_	_	_	_
26-36	3653-3658	water	substance	new	_	_
26-37	3659-3660	.	_	_	_	_

#Text=In addition , the amino groups of CA are protonated at physiological pH and can interact with negatively charged molecules , favoring the formation of a stable assembly by electrostatic interactions .
27-1	3661-3663	In	_	_	_	_
27-2	3664-3672	addition	_	_	_	_
27-3	3673-3674	,	_	_	_	_
27-4	3675-3678	the	person[189]	giv[189]	coref	30-20[212_189]
27-5	3679-3684	amino	object|person[189]	giv|giv[189]	coref	30-20
27-6	3685-3691	groups	person[189]	giv[189]	_	_
27-7	3692-3694	of	_	_	_	_
27-8	3695-3697	CA	_	_	_	_
27-9	3698-3701	are	_	_	_	_
27-10	3702-3712	protonated	_	_	_	_
27-11	3713-3715	at	_	_	_	_
27-12	3716-3729	physiological	quantity[190]	giv[190]	coref	37-15[261_190]
27-13	3730-3732	pH	quantity[190]	giv[190]	_	_
27-14	3733-3736	and	_	_	_	_
27-15	3737-3740	can	_	_	_	_
27-16	3741-3749	interact	_	_	_	_
27-17	3750-3754	with	_	_	_	_
27-18	3755-3765	negatively	object[191]	new[191]	coref	28-15[198_191]
27-19	3766-3773	charged	object[191]	new[191]	_	_
27-20	3774-3783	molecules	object[191]	new[191]	_	_
27-21	3784-3785	,	_	_	_	_
27-22	3786-3794	favoring	_	_	_	_
27-23	3795-3798	the	event[192]	new[192]	_	_
27-24	3799-3808	formation	event[192]	new[192]	_	_
27-25	3809-3811	of	event[192]	new[192]	_	_
27-26	3812-3813	a	event[192]|organization[193]	new[192]|new[193]	_	_
27-27	3814-3820	stable	event[192]|organization[193]	new[192]|new[193]	_	_
27-28	3821-3829	assembly	event[192]|organization[193]	new[192]|new[193]	_	_
27-29	3830-3832	by	event[192]|organization[193]	new[192]|new[193]	_	_
27-30	3833-3846	electrostatic	event[192]|organization[193]|abstract[194]	new[192]|new[193]|new[194]	coref	38-13[267_194]
27-31	3847-3859	interactions	event[192]|organization[193]|abstract[194]	new[192]|new[193]|new[194]	_	_
27-32	3860-3861	.	_	_	_	_

#Text=There are some works based on amino-coated QDs as nanosensors for the determination of different molecules .
28-1	3862-3867	There	_	_	_	_
28-2	3868-3871	are	_	_	_	_
28-3	3872-3876	some	abstract[195]	giv[195]	_	_
28-4	3877-3882	works	abstract[195]	giv[195]	_	_
28-5	3883-3888	based	_	_	_	_
28-6	3889-3891	on	_	_	_	_
28-7	3892-3904	amino-coated	abstract[196]	giv[196]	coref	29-13[203_196]
28-8	3905-3908	QDs	abstract[196]	giv[196]	_	_
28-9	3909-3911	as	abstract[196]	giv[196]	_	_
28-10	3912-3923	nanosensors	abstract[196]	giv[196]	_	_
28-11	3924-3927	for	abstract[196]	giv[196]	_	_
28-12	3928-3931	the	abstract[196]|abstract[197]	giv[196]|new[197]	_	_
28-13	3932-3945	determination	abstract[196]|abstract[197]	giv[196]|new[197]	_	_
28-14	3946-3948	of	abstract[196]|abstract[197]	giv[196]|new[197]	_	_
28-15	3949-3958	different	abstract[196]|abstract[197]|object[198]	giv[196]|new[197]|giv[198]	_	_
28-16	3959-3968	molecules	abstract[196]|abstract[197]|object[198]	giv[196]|new[197]|giv[198]	_	_
28-17	3969-3970	.	_	_	_	_

#Text=However , to our knowledge , there are no reports based on CdTe/CA QDs for the determination of FA .
29-1	3971-3978	However	_	_	_	_
29-2	3979-3980	,	_	_	_	_
29-3	3981-3983	to	_	_	_	_
29-4	3984-3987	our	person|abstract[200]	acc|new[200]	ana	32-5
29-5	3988-3997	knowledge	abstract[200]	new[200]	_	_
29-6	3998-3999	,	_	_	_	_
29-7	4000-4005	there	_	_	_	_
29-8	4006-4009	are	_	_	_	_
29-9	4010-4012	no	abstract[201]	new[201]	_	_
29-10	4013-4020	reports	abstract[201]	new[201]	_	_
29-11	4021-4026	based	_	_	_	_
29-12	4027-4029	on	_	_	_	_
29-13	4030-4037	CdTe/CA	abstract|abstract[203]	new|giv[203]	coref|coref	30-17[0_203]|33-1
29-14	4038-4041	QDs	abstract[203]	giv[203]	_	_
29-15	4042-4045	for	_	_	_	_
29-16	4046-4049	the	abstract[204]	giv[204]	coref	32-18[227_204]
29-17	4050-4063	determination	abstract[204]	giv[204]	_	_
29-18	4064-4066	of	abstract[204]	giv[204]	_	_
29-19	4067-4069	FA	abstract[204]|abstract	giv[204]|giv	coref	30-29
29-20	4070-4071	.	_	_	_	_

#Text=Therefore , the objective of the present work is the development of a sensor based on QDs coated with amino groups and its application in the determination of FA in commercial beverages .
30-1	4072-4081	Therefore	_	_	_	_
30-2	4082-4083	,	_	_	_	_
30-3	4084-4087	the	abstract[206]	new[206]	coref	30-10[208_206]
30-4	4088-4097	objective	abstract[206]	new[206]	_	_
30-5	4098-4100	of	abstract[206]	new[206]	_	_
30-6	4101-4104	the	abstract[206]|abstract[207]	new[206]|new[207]	coref	32-2[221_207]
30-7	4105-4112	present	abstract[206]|abstract[207]	new[206]|new[207]	_	_
30-8	4113-4117	work	abstract[206]|abstract[207]	new[206]|new[207]	_	_
30-9	4118-4120	is	_	_	_	_
30-10	4121-4124	the	abstract[208]	giv[208]	_	_
30-11	4125-4136	development	abstract[208]	giv[208]	_	_
30-12	4137-4139	of	abstract[208]	giv[208]	_	_
30-13	4140-4141	a	abstract[208]|object[209]	giv[208]|giv[209]	coref	31-10[220_209]
30-14	4142-4148	sensor	abstract[208]|object[209]	giv[208]|giv[209]	_	_
30-15	4149-4154	based	_	_	_	_
30-16	4155-4157	on	_	_	_	_
30-17	4158-4161	QDs	abstract	giv	ana	30-23
30-18	4162-4168	coated	_	_	_	_
30-19	4169-4173	with	_	_	_	_
30-20	4174-4179	amino	object|person[212]	giv|giv[212]	coref	38-33[275_212]
30-21	4180-4186	groups	person[212]	giv[212]	_	_
30-22	4187-4190	and	person[212]	giv[212]	_	_
30-23	4191-4194	its	person[212]|abstract|abstract[214]	giv[212]|giv|new[214]	coref|coref	32-11[225_0]|41-14[0_214]
30-24	4195-4206	application	person[212]|abstract[214]	giv[212]|new[214]	_	_
30-25	4207-4209	in	person[212]|abstract[214]	giv[212]|new[214]	_	_
30-26	4210-4213	the	person[212]|abstract[214]|abstract[215]	giv[212]|new[214]|new[215]	_	_
30-27	4214-4227	determination	person[212]|abstract[214]|abstract[215]	giv[212]|new[214]|new[215]	_	_
30-28	4228-4230	of	person[212]|abstract[214]|abstract[215]	giv[212]|new[214]|new[215]	_	_
30-29	4231-4233	FA	person[212]|abstract[214]|abstract[215]|substance	giv[212]|new[214]|new[215]|giv	coref	32-21
30-30	4234-4236	in	person[212]|abstract[214]|abstract[215]	giv[212]|new[214]|new[215]	_	_
30-31	4237-4247	commercial	person[212]|abstract[214]|abstract[215]|substance[217]	giv[212]|new[214]|new[215]|giv[217]	coref	40-11[0_217]
30-32	4248-4257	beverages	person[212]|abstract[214]|abstract[215]|substance[217]	giv[212]|new[214]|new[215]|giv[217]	_	_
30-33	4258-4259	.	_	_	_	_

#Text=The proposed design should improve the analytical characteristics of the sensor .
31-1	4260-4263	The	abstract[218]	new[218]	_	_
31-2	4264-4272	proposed	abstract[218]	new[218]	_	_
31-3	4273-4279	design	abstract[218]	new[218]	_	_
31-4	4280-4286	should	_	_	_	_
31-5	4287-4294	improve	_	_	_	_
31-6	4295-4298	the	abstract[219]	giv[219]	_	_
31-7	4299-4309	analytical	abstract[219]	giv[219]	_	_
31-8	4310-4325	characteristics	abstract[219]	giv[219]	_	_
31-9	4326-4328	of	abstract[219]	giv[219]	_	_
31-10	4329-4332	the	abstract[219]|object[220]	giv[219]|giv[220]	_	_
31-11	4333-4339	sensor	abstract[219]|object[220]	giv[219]|giv[220]	_	_
31-12	4340-4341	.	_	_	_	_

#Text=In this work , we present a system based on water-soluble CdTe QDs coated with CA for the determination of FA .
32-1	4342-4344	In	_	_	_	_
32-2	4345-4349	this	abstract[221]	giv[221]	_	_
32-3	4350-4354	work	abstract[221]	giv[221]	_	_
32-4	4355-4356	,	_	_	_	_
32-5	4357-4359	we	person	giv	_	_
32-6	4360-4367	present	_	_	_	_
32-7	4368-4369	a	abstract[223]	new[223]	coref	35-10[249_223]
32-8	4370-4376	system	abstract[223]	new[223]	_	_
32-9	4377-4382	based	_	_	_	_
32-10	4383-4385	on	_	_	_	_
32-11	4386-4399	water-soluble	abstract[225]	giv[225]	coref	34-5[240_225]
32-12	4400-4404	CdTe	substance|abstract[225]	new|giv[225]	coref	34-5
32-13	4405-4408	QDs	abstract[225]	giv[225]	_	_
32-14	4409-4415	coated	_	_	_	_
32-15	4416-4420	with	_	_	_	_
32-16	4421-4423	CA	substance	giv	coref	34-9
32-17	4424-4427	for	_	_	_	_
32-18	4428-4431	the	abstract[227]	giv[227]	coref	35-16[251_227]
32-19	4432-4445	determination	abstract[227]	giv[227]	_	_
32-20	4446-4448	of	abstract[227]	giv[227]	_	_
32-21	4449-4451	FA	abstract[227]|abstract	giv[227]|giv	coref	34-11
32-22	4452-4453	.	_	_	_	_

#Text=CdTe/CA was prepared and characterized by high-resolution transmission electron microscopy , FT-IR spectroscopy , the zeta potential , and UV-visible and fluorescence spectroscopy .
33-1	4454-4461	CdTe/CA	object	giv	coref	35-2
33-2	4462-4465	was	_	_	_	_
33-3	4466-4474	prepared	_	_	_	_
33-4	4475-4478	and	_	_	_	_
33-5	4479-4492	characterized	_	_	_	_
33-6	4493-4495	by	_	_	_	_
33-7	4496-4511	high-resolution	object[230]	new[230]	appos	33-9[232_230]
33-8	4512-4524	transmission	object[230]	new[230]	_	_
33-9	4525-4533	electron	substance|object[232]	new|giv[232]	_	_
33-10	4534-4544	microscopy	object[232]	giv[232]	_	_
33-11	4545-4546	,	object[232]	giv[232]	_	_
33-12	4547-4552	FT-IR	object[232]|abstract|abstract[234]	giv[232]|new|giv[234]	coref	33-20[237_234]
33-13	4553-4565	spectroscopy	object[232]|abstract[234]	giv[232]|giv[234]	_	_
33-14	4566-4567	,	object[232]	giv[232]	_	_
33-15	4568-4571	the	object[232]|abstract[235]	giv[232]|new[235]	coref	41-13[301_235]
33-16	4572-4576	zeta	object[232]|abstract[235]	giv[232]|new[235]	_	_
33-17	4577-4586	potential	object[232]|abstract[235]	giv[232]|new[235]	_	_
33-18	4587-4588	,	object[232]	giv[232]	_	_
33-19	4589-4592	and	object[232]	giv[232]	_	_
33-20	4593-4603	UV-visible	object[232]|abstract[237]	giv[232]|giv[237]	_	_
33-21	4604-4607	and	object[232]|abstract[237]	giv[232]|giv[237]	_	_
33-22	4608-4620	fluorescence	object[232]|abstract|abstract[237]	giv[232]|giv|giv[237]	coref	37-7
33-23	4621-4633	spectroscopy	object[232]|abstract[237]	giv[232]|giv[237]	_	_
33-24	4634-4635	.	_	_	_	_

#Text=The analytical response of CdTe QDs capped with CA toward FA was studied and compared to the results obtained using other thiol-capped QDs .
34-1	4636-4639	The	abstract[238]	new[238]	_	_
34-2	4640-4650	analytical	abstract[238]	new[238]	_	_
34-3	4651-4659	response	abstract[238]	new[238]	_	_
34-4	4660-4662	of	abstract[238]	new[238]	_	_
34-5	4663-4667	CdTe	abstract[238]|substance|abstract[240]	new[238]|giv|giv[240]	coref	34-21[244_240]
34-6	4668-4671	QDs	abstract[238]|abstract[240]	new[238]|giv[240]	_	_
34-7	4672-4678	capped	_	_	_	_
34-8	4679-4683	with	_	_	_	_
34-9	4684-4686	CA	substance	giv	_	_
34-10	4687-4693	toward	_	_	_	_
34-11	4694-4696	FA	substance	giv	coref	35-16
34-12	4697-4700	was	_	_	_	_
34-13	4701-4708	studied	_	_	_	_
34-14	4709-4712	and	_	_	_	_
34-15	4713-4721	compared	_	_	_	_
34-16	4722-4724	to	_	_	_	_
34-17	4725-4728	the	abstract[243]	new[243]	coref	40-4[289_243]
34-18	4729-4736	results	abstract[243]	new[243]	_	_
34-19	4737-4745	obtained	_	_	_	_
34-20	4746-4751	using	_	_	_	_
34-21	4752-4757	other	abstract[244]	giv[244]	coref	35-2[246_244]
34-22	4758-4770	thiol-capped	abstract[244]	giv[244]	_	_
34-23	4771-4774	QDs	abstract[244]	giv[244]	_	_
34-24	4775-4776	.	_	_	_	_

#Text=As CdTe/CA QDs showed the largest quenching efficiency , this system was further studied for FA determination .
35-1	4777-4779	As	_	_	_	_
35-2	4780-4787	CdTe/CA	abstract|abstract[246]	giv|giv[246]	coref|coref	37-10|37-10[259_246]
35-3	4788-4791	QDs	abstract[246]	giv[246]	_	_
35-4	4792-4798	showed	_	_	_	_
35-5	4799-4802	the	abstract[248]	new[248]	_	_
35-6	4803-4810	largest	abstract[248]	new[248]	_	_
35-7	4811-4820	quenching	abstract|abstract[248]	new|new[248]	coref	37-6[257_0]
35-8	4821-4831	efficiency	abstract[248]	new[248]	_	_
35-9	4832-4833	,	_	_	_	_
35-10	4834-4838	this	abstract[249]	giv[249]	coref	41-1[296_249]
35-11	4839-4845	system	abstract[249]	giv[249]	_	_
35-12	4846-4849	was	_	_	_	_
35-13	4850-4857	further	_	_	_	_
35-14	4858-4865	studied	_	_	_	_
35-15	4866-4869	for	_	_	_	_
35-16	4870-4872	FA	abstract|abstract[251]	giv|giv[251]	coref	37-13[260_0]
35-17	4873-4886	determination	abstract[251]	giv[251]	_	_
35-18	4887-4888	.	_	_	_	_

#Text=The principle of this nanosensor is illustrated in Scheme 1 .
36-1	4889-4892	The	abstract[252]	new[252]	_	_
36-2	4893-4902	principle	abstract[252]	new[252]	_	_
36-3	4903-4905	of	abstract[252]	new[252]	_	_
36-4	4906-4910	this	abstract[252]|object[253]	new[252]|new[253]	coref	39-1[283_253]
36-5	4911-4921	nanosensor	abstract[252]|object[253]	new[252]|new[253]	_	_
36-6	4922-4924	is	_	_	_	_
36-7	4925-4936	illustrated	_	_	_	_
36-8	4937-4939	in	_	_	_	_
36-9	4940-4946	Scheme	abstract[254]	new[254]	_	_
36-10	4947-4948	1	abstract[254]	new[254]	_	_
36-11	4949-4950	.	_	_	_	_

#Text=The probe is based on the fluorescence quenching of CdTe/CA QDs by FA at pH 8 .
37-1	4951-4954	The	object[255]	new[255]	_	_
37-2	4955-4960	probe	object[255]	new[255]	_	_
37-3	4961-4963	is	_	_	_	_
37-4	4964-4969	based	_	_	_	_
37-5	4970-4972	on	_	_	_	_
37-6	4973-4976	the	abstract[257]	giv[257]	coref	38-5[264_257]
37-7	4977-4989	fluorescence	abstract|abstract[257]	giv|giv[257]	coref	38-5
37-8	4990-4999	quenching	abstract[257]	giv[257]	_	_
37-9	5000-5002	of	abstract[257]	giv[257]	_	_
37-10	5003-5010	CdTe/CA	abstract[257]|substance|abstract[259]	giv[257]|giv|giv[259]	coref|coref	38-18|38-16[269_259]
37-11	5011-5014	QDs	abstract[257]|abstract[259]	giv[257]|giv[259]	_	_
37-12	5015-5017	by	abstract[257]|abstract[259]	giv[257]|giv[259]	_	_
37-13	5018-5020	FA	abstract[257]|abstract[259]|abstract[260]	giv[257]|giv[259]|giv[260]	coref	38-31[0_260]
37-14	5021-5023	at	abstract[257]|abstract[259]|abstract[260]	giv[257]|giv[259]|giv[260]	_	_
37-15	5024-5026	pH	abstract[257]|abstract[259]|abstract[260]|abstract[261]	giv[257]|giv[259]|giv[260]|giv[261]	_	_
37-16	5027-5028	8	abstract[257]|abstract[259]|abstract[260]|abstract[261]	giv[257]|giv[259]|giv[260]|giv[261]	_	_
37-17	5029-5030	.	_	_	_	_

#Text=A probable mechanism of fluorescence quenching based on the coordinated behavior of electrostatic interactions between positively charged CdTe/CA QDs ( ethylamine groups , pKa = 10.52 ) and negatively charged FA ( carboxylic groups , pKaα = 3.46 and pKaγ = 4.83 ) and the electronic transfer of QDs to FA is proposed .
38-1	5031-5032	A	abstract[262]	new[262]	_	_
38-2	5033-5041	probable	abstract[262]	new[262]	_	_
38-3	5042-5051	mechanism	abstract[262]	new[262]	_	_
38-4	5052-5054	of	abstract[262]	new[262]	_	_
38-5	5055-5067	fluorescence	abstract[262]|abstract|abstract[264]	new[262]|giv|giv[264]	_	_
38-6	5068-5077	quenching	abstract[262]|abstract[264]	new[262]|giv[264]	_	_
38-7	5078-5083	based	_	_	_	_
38-8	5084-5086	on	_	_	_	_
38-9	5087-5090	the	abstract[265]	new[265]	_	_
38-10	5091-5102	coordinated	abstract[265]	new[265]	_	_
38-11	5103-5111	behavior	abstract[265]	new[265]	_	_
38-12	5112-5114	of	abstract[265]	new[265]	_	_
38-13	5115-5128	electrostatic	abstract[265]|abstract|abstract[267]	new[265]|new|giv[267]	_	_
38-14	5129-5141	interactions	abstract[265]|abstract[267]	new[265]|giv[267]	_	_
38-15	5142-5149	between	abstract[265]|abstract[267]	new[265]|giv[267]	_	_
38-16	5150-5160	positively	abstract[265]|abstract[267]|substance[269]	new[265]|giv[267]|giv[269]	appos	38-21[271_269]
38-17	5161-5168	charged	abstract[265]|abstract[267]|substance[269]	new[265]|giv[267]|giv[269]	_	_
38-18	5169-5176	CdTe/CA	abstract[265]|abstract[267]|substance|substance[269]	new[265]|giv[267]|giv|giv[269]	_	_
38-19	5177-5180	QDs	abstract[265]|abstract[267]|substance[269]	new[265]|giv[267]|giv[269]	_	_
38-20	5181-5182	(	_	_	_	_
38-21	5183-5193	ethylamine	abstract|substance[271]	new|giv[271]	coref	38-49[0_271]
38-22	5194-5200	groups	substance[271]	giv[271]	_	_
38-23	5201-5202	,	_	_	_	_
38-24	5203-5206	pKa	substance	new	_	_
38-25	5207-5208	=	_	_	_	_
38-26	5209-5214	10.52	quantity	new	_	_
38-27	5215-5216	)	_	_	_	_
38-28	5217-5220	and	_	_	_	_
38-29	5221-5231	negatively	_	_	_	_
38-30	5232-5239	charged	_	_	_	_
38-31	5240-5242	FA	substance	giv	coref	38-51
38-32	5243-5244	(	_	_	_	_
38-33	5245-5255	carboxylic	person[275]	giv[275]	_	_
38-34	5256-5262	groups	person[275]	giv[275]	_	_
38-35	5263-5264	,	_	_	_	_
38-36	5265-5269	pKaα	quantity	new	_	_
38-37	5270-5271	=	_	_	_	_
38-38	5272-5276	3.46	quantity	new	_	_
38-39	5277-5280	and	_	_	_	_
38-40	5281-5285	pKaγ	abstract	new	_	_
38-41	5286-5287	=	_	_	_	_
38-42	5288-5292	4.83	quantity	new	_	_
38-43	5293-5294	)	_	_	_	_
38-44	5295-5298	and	_	_	_	_
38-45	5299-5302	the	abstract[280]	new[280]	_	_
38-46	5303-5313	electronic	abstract[280]	new[280]	_	_
38-47	5314-5322	transfer	abstract[280]	new[280]	_	_
38-48	5323-5325	of	abstract[280]	new[280]	_	_
38-49	5326-5329	QDs	abstract[280]|substance	new[280]|giv	_	_
38-50	5330-5332	to	abstract[280]	new[280]	_	_
38-51	5333-5335	FA	abstract[280]|substance	new[280]|giv	coref	40-8
38-52	5336-5338	is	_	_	_	_
38-53	5339-5347	proposed	_	_	_	_
38-54	5348-5349	.	_	_	_	_

#Text=The nanosensor is rapid , easy to obtain , and shows a low detection limit , high selectivity , and low cost .
39-1	5350-5353	The	object[283]	giv[283]	_	_
39-2	5354-5364	nanosensor	object[283]	giv[283]	_	_
39-3	5365-5367	is	_	_	_	_
39-4	5368-5373	rapid	_	_	_	_
39-5	5374-5375	,	_	_	_	_
39-6	5376-5380	easy	_	_	_	_
39-7	5381-5383	to	_	_	_	_
39-8	5384-5390	obtain	_	_	_	_
39-9	5391-5392	,	_	_	_	_
39-10	5393-5396	and	_	_	_	_
39-11	5397-5402	shows	_	_	_	_
39-12	5403-5404	a	abstract[285]	new[285]	_	_
39-13	5405-5408	low	abstract[285]	new[285]	_	_
39-14	5409-5418	detection	abstract|abstract[285]	giv|new[285]	_	_
39-15	5419-5424	limit	abstract[285]	new[285]	_	_
39-16	5425-5426	,	_	_	_	_
39-17	5427-5431	high	abstract[286]	new[286]	_	_
39-18	5432-5443	selectivity	abstract[286]	new[286]	_	_
39-19	5444-5445	,	_	_	_	_
39-20	5446-5449	and	_	_	_	_
39-21	5450-5453	low	abstract[287]	new[287]	_	_
39-22	5454-5458	cost	abstract[287]	new[287]	_	_
39-23	5459-5460	.	_	_	_	_

#Text=The method showed excellent results in detecting FA contents in beverages ( recoveries from 98.3 to 103.9 % ) .
40-1	5461-5464	The	abstract[288]	new[288]	_	_
40-2	5465-5471	method	abstract[288]	new[288]	_	_
40-3	5472-5478	showed	_	_	_	_
40-4	5479-5488	excellent	abstract[289]	giv[289]	_	_
40-5	5489-5496	results	abstract[289]	giv[289]	_	_
40-6	5497-5499	in	_	_	_	_
40-7	5500-5509	detecting	_	_	_	_
40-8	5510-5512	FA	substance|object[291]	giv|new[291]	_	_
40-9	5513-5521	contents	object[291]	new[291]	_	_
40-10	5522-5524	in	_	_	_	_
40-11	5525-5534	beverages	substance	giv	_	_
40-12	5535-5536	(	_	_	_	_
40-13	5537-5547	recoveries	event[293]	new[293]	_	_
40-14	5548-5552	from	event[293]	new[293]	_	_
40-15	5553-5557	98.3	event[293]|quantity[294]	new[293]|new[294]	_	_
40-16	5558-5560	to	event[293]|quantity[294]	new[293]|new[294]	_	_
40-17	5561-5566	103.9	event[293]|quantity[294]|quantity[295]	new[293]|new[294]|new[295]	_	_
40-18	5567-5568	%	event[293]|quantity[294]|quantity[295]	new[293]|new[294]|new[295]	_	_
40-19	5569-5570	)	_	_	_	_
40-20	5571-5572	.	_	_	_	_

#Text=The system provides a new approach for the construction of nanosensors with high application potential in different areas .
41-1	5573-5576	The	abstract[296]	giv[296]	_	_
41-2	5577-5583	system	abstract[296]	giv[296]	_	_
41-3	5584-5592	provides	_	_	_	_
41-4	5593-5594	a	abstract[297]	new[297]	_	_
41-5	5595-5598	new	abstract[297]	new[297]	_	_
41-6	5599-5607	approach	abstract[297]	new[297]	_	_
41-7	5608-5611	for	abstract[297]	new[297]	_	_
41-8	5612-5615	the	abstract[297]|abstract[298]	new[297]|new[298]	_	_
41-9	5616-5628	construction	abstract[297]|abstract[298]	new[297]|new[298]	_	_
41-10	5629-5631	of	abstract[297]|abstract[298]	new[297]|new[298]	_	_
41-11	5632-5643	nanosensors	abstract[297]|abstract[298]|object[299]	new[297]|new[298]|new[299]	_	_
41-12	5644-5648	with	abstract[297]|abstract[298]|object[299]	new[297]|new[298]|new[299]	_	_
41-13	5649-5653	high	abstract[297]|abstract[298]|object[299]|abstract[301]	new[297]|new[298]|new[299]|giv[301]	_	_
41-14	5654-5665	application	abstract[297]|abstract[298]|object[299]|abstract|abstract[301]	new[297]|new[298]|new[299]|giv|giv[301]	_	_
41-15	5666-5675	potential	abstract[297]|abstract[298]|object[299]|abstract[301]	new[297]|new[298]|new[299]|giv[301]	_	_
41-16	5676-5678	in	abstract[297]|abstract[298]|object[299]|abstract[301]	new[297]|new[298]|new[299]|giv[301]	_	_
41-17	5679-5688	different	abstract[297]|abstract[298]|object[299]|abstract[301]|abstract[302]	new[297]|new[298]|new[299]|giv[301]|new[302]	_	_
41-18	5689-5694	areas	abstract[297]|abstract[298]|object[299]|abstract[301]|abstract[302]	new[297]|new[298]|new[299]|giv[301]|new[302]	_	_
41-19	5695-5696	.	_	_	_	_
